Mechanisms involved include complement deficiency, abnormal upregulation of type I IFNs, JAK‐STAT pathway dysfunction, ineffective central and peripheral tolerance, apoptosis defects and low production of ROS. The gene discussed is SOAT1; the disease is complement deficiency.